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Abstract
Mice lacking expression of the ß2 subunit of the neuronal nicotinic acetylcholine receptor (CHRNB2) display abnormal
retinal waves and a dispersed projection of retinal ganglion cell (RGC) axons to their dorsal lateral geniculate nuclei (dLGNs).
Transcriptomes of LGN tissue from two independently generated Chrnb22/2 mutants and from wildtype mice were
obtained at postnatal day 4 (P4), during the normal period of segregation of eye-specific afferents to the LGN. Microarray
analysis reveals reduced expression of genes located on the cell membrane or in extracellular space, and of genes active in
cell adhesion and calcium signaling. In particular, mRNA for cadherin 1 (Cdh1), a known axon growth regulator, is reduced
to nearly undetectable levels in the LGN of P4 mutant mice and Lypd2 mRNA is similarly suppressed. Similar analysis of
retinal tissue shows increased expression of crumbs 1 (Crb1) and chemokine (C-C motif) ligand 21 (Ccl21) mRNAs in
Chrnb22/2 mutant animals. Mutations in these genes are associated with retinal neuronal degeneration. The retinas of
Chrnb22/2 mutants are normal in appearance, but the increased expression of these genes may also be involved in the
abnormal projection patterns of RGC to the LGN. These data may provide the tools to distinguish the interplay between
neural activity and molecular expression. Finally, comparison of the transcriptomes of the two different Chrnb22/2 mutant
strains reveals the effects of genetic background upon gene expression.
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Introduction
Mutant mice provide an invaluable tool for studying the
development and organization of the mammalian visual system
[1]. Eye specific segregation develops in the lateral geniculate
nucleus (LGN) and superior colliculus of mice as an initially
intermingled pattern of retinal ganglion cell (RGC) projections
that gives way to eye specific regions by postnatal day 8 (P8). Mice
with a deletion of the gene for the ß2 subunit of the nicotinic
acetylcholine receptor (Chrnb22/2 mutants) have served as a
popular model for studying visual system development
[2,3,4,5,6,7,8]. In Chrnb22/2 mutants the projections of the
two eyes remain intermingled in the LGN at P8 but form an
altered eye specific segregated pattern by P14 [2,6,7]. Retinotopic
organization is less precise [5,8,9], and the receptive field
properties of LGN and visual cortical neurons are abnormal in
the Chrnb22/2 mutants compared to wild type (WT) animals
[3,4,9].
Coordinated firing of action potentials that sweep across the
retina in a wavelike manner (retinal waves) occur in the WT retina
from the late embryonic stage to eye opening in the mouse [2].
Retinal waves are believed to drive development of the eye specific
segregation pattern in the LGN, as blocking retinal waves with
intraocular injections of epibatidine blocks eye specific segregation
[10,11,12,13]. Application of antagonists to retinal ß2 nAChRs
also blocks expression of retinal waves [14]. As expected from
these results, Chrn2b2/2 mutant mice were intitally reported to
lack retinal waves [14,15] It has recently been demonstrated that
the Chrnb22/2 mutants do manifest retinal waves, though the
waves are not normal in their spatial or temporal characteristics
[15,16].
The aberrations in the structural and functional organization of
the Chrnb22/2 mutant animals are thought to reflect the
abnormal retinal activity that occurs during the developmental
period when key features of the visual system are being established.
Whether or not the structural and functional abnormalities that
have been documented in the Chrnb22/2 mutants are driven by
abnormal patterns of retinal activity during development, the
aberrations displayed by the visual system of the Chrnb22/2
mutants presumably also reflect the abnormal expression of
molecules that play a role in forming the patterns of connections in
the developing visual system. As a first step in probing this matter,
in the present study we have used microarray technology to
compare the expression of molecules in the retina and the LGN of
the Chrnb22/2mutants with those of WT animals during the
period of eye specific segregation in the LGN.
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Animals
All experiments were performed in accordance with NIH and
institutional guidelines regarding animal use and were approved
by the campus animal use and care committee of the University of
California, Davis. WT (C57BL/6J) mice were obtained from
Jackson Laboratory (Bar Harbor, Maine), Picciotto (‘‘Pic’’)
Chrnb22/2 mutant mice were a kind gift from Dr. M Picciotto
[17] and Xu mutants were derived from embryos (ES Cell line ID
00211-UNC) supplied through the Mutant Mouse Regional
Resource Center (University of California, Davis, California).
Neonatal mice were administered a lethal IP dose (0.05–0.1 ml) of
Fatal Plus (Vortech Pharmaceuticals; Dearborn, MI) at the time of
tissue collection. Tail snips were collected from mutant mice for
genotyping to confirm mutation.
Microarray tissue preparation, hybridization, and analysis
Total retinas from three male P4 littermates from timed
pregnancies were harvested and immediately placed on dry ice.
Tissue was maintained at 280uC until RNA was prepared. Mice
were homozygous Picciotto Chrnb22/2,X uChrnb22/2,o r
C57BL/6J WT animals. Retinas from each animal were separated
from the sclera and were combined. RNA was isolated with the
RNAeasy Mini kit (Qiagen). A total of 500 ng of RNA was
amplified with Ambion MessageAmp II-Biotin Enhanced reagents
(AM1791) and aRNA yields were 57–122 mg. Twenty micrograms
of each aRNA target (9 samples total) were fragmented and
hybridized to Affymetrix GeneChip Mouse 430 2.0 expression
arrays using the Affymetrix GeneChip Fluidics Station and
Affymetrix reagents (Affymetrix). Adult retinal tissue was prepared
as above but only two male littermates of each type were sampled.
Total LGN (including both dorsal and ventral portions) was
isolated from a second set of male P4 littermates under the
dissecting microscope. The cortex was removed and the LGNs
were visualized and excised using an 18G needle. The LGN was
isolated as a discrete entity without any surrounding thalamic
tissue attached. Left and right LGN were combined for each
animal and frozen on dry ice. RNA was prepared and amplified as
described for retinas, but the aRNA yield from 500 ng of LGN
RNA was much lower, 10–31 mg. Ten micrograms of each aRNA
target (9 samples total) were fragmented and hybridized as
described for retinal samples.
Both the retinal and LGN tissue contain a mixture of cell types.
Chip data were analyzed with dChip software [18], using
quantile normalization and PM/MM modeling. Present calls were
above 50% for all samples (Table S1). Thresholds chosen for WT
vs. mutant analyses were 1.5-fold minimum change between WT
and KO and difference $50, and probe sets in both Picciotto and
Xu mutants had to differ from WT in the same direction (i.e.,
either overexpressed in WT or overexpressed in both mutants).
The difference parameter excludes probe sets detected only at very
low levels. For Picciotto vs Xu mutant analyses the minimum fold
change was increased to 2.0. One P4 LGN WT hybridization (WT
E) showed a high percentage of outliers and was omitted from
analysis (Table S1). Excel data files using the threshold values
described above are presented as Tables S2 and S3. Affymetrix
CEL files are available under GEO Series Record #GSE22824.
Immunohistochemistry
Following euthanasia, eyes from WT and mutant animals were
enucleated then fixed in 4% PFA in PBS for 30–45 minutes. After
cryoprotection in a 25% sucrose solution each eye was embedded
in OCT (Ted Pella, Torrence, CA), sectioned at 10 mm on a Leica
(Deerfield, IL) cryostat, and mounted on glass slides. Brains from
WT and mutant animals were harvested and the unfixed brain was
embedded in OCT, frozen on dry ice, sectioned at 15 mmo na
cryostat (Leica), mounted on glass slides and stored at 280uC until
used. Before processing for immunohistochemistry, brain section
slides were warmed to room temperature, fixed in 4% PFA for 2–
4 minutes and washed in PBS.
For immunostaining, sections were blocked in 10% normal
donkey serum, 2% bovine serum albumin, and 0.3% Triton X in
PBS for 2 hours, then incubated in blocking solution overnight at
4uC with primary antibodies used as follows: Anti-CHRNB2
M270 (1:250 n8408, Sigma, St Louis, MO), anti-CHRNB2 (1:250,
sc-1449, Santa Cruz Biotechnology, Santa Cruz, CA), anti-CCL21
(1:500; sc-25445, Santa Cruz Biotechnology), anti-CDH1 (1:50;
610181,BD Biosciences, San Jose CA) and anti-SPP1 (1:100; 01-
20002, American Research Products, Belmont MA), followed by
incubation with Alexa Fluor 568 or 594 fluorescent secondaries
(1:500; Invitrogen, Carlsbad, CA), or CY3 (1:500; Jackson
ImmunoResearch Laboratory., Inc., West Grove, PA) for 1 hour.
Nuclei were visualized with DAPI (1:500; KPL, Gaithersburg,
MD) and sections were coverslipped using Vectashield (Vector
Laboratories, Burlingame, CA). For control slides primary
antibodies were omitted. Images were acquired on an Olympus
FV500 confocal microscope (Olympus, Japan). Brightness and
contrast were adjusted using Adobe Photoshop.
Retinal projections to LGN
Retinal projections were traced by making intraocular injections
of cholera toxin-ß (CTB) conjugated to fluorescent dyes (Molec-
ular Probes). Twenty four hours prior to the required time points,
(P4, P8) mice were anesthetized by immersion in ice water and
intraocular injections of 1 ml of CTB conjugated to Alexa 488 (left
eye) and Alexa 594 (right eye) in 0.5% saline were made into the
far temporal region of the eye with a micro pipette. The eyes were
treated with ophthalmic antibiotic and the animals placed on a
warm surface until full movement was regained. After euthanasia,
the brains were removed and immersion fixed with 4%
paraformaldehyde for 48 hours. The brains were then sectioned
at 50 mm on a vibratome (Leica), mounted on glass slides, cover
slipped, then imaged on a Nikon Eclipse E600 upright microscope
equipped with an ORCA-ER C4742-90 CCD camera (Hama-
matsu Photonics) using a 106 objective. Images were pseudo
colored using Wasabi software (Hamamatsu).
RT-PCR
Qualitative RT-PCR was performed to validate the microarray
assay for selected genes of interest. Qiagen OneStep RT-PCR
reagents were used with the protocol recommended by the
manufacturer. Ten to 20 ng of each template RNA was used per
25 ml reaction volume. Negative controls were run without added
template. At 20–35 cycles aliquots of each reaction were withdrawn
and run on agarose gels. Gel images have been adjusted for
brightness and contrast with Adobe Photoshop. Actin control RT-
PCRs are shown in Figure S1. Primers used are given in Table 1.
Results
Genetic background of the two Chrnb22/2 mutant
strains contributes to changes in their transcriptomes
Comparison of the two mutant strains with each other and with
the WT strain (C57BL/6J) reveals the genes truly affected by lack
of Chrnb2 expression vs. those resulting from inter-strain differenc-
es. The importance of the contribution of the mouse background
strain to the transcriptional profile has been noted by others
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Picciotto P4 LGN, 15 genes display significantly altered expression
by the chosen stringency criteria (Figure 1A). Two genes (Erdr1
and Traf4) differ between the two mutants in the P4 retina
(Figure 1B), while hundreds of genes showed different expression
between the two mutant adult retinas (Table S3). However, the
difference in Erdr1 and Traf4 expression is no longer evident in the
adult retina. Only two adult retinas were sampled for each type of
mouse, vs. three each for P4 mice, and many lens proteins appear
in the differentially expressed genes in the adult mice. We attribute
most of the variation in the adult samples to the small sample size
and dissection artifacts.
Expression of at least two genes which show significantly
different expression between mutant and WT animals may also be
affected by background strain. The Xlr3a gene, which is
overexpressed in P4 mutant LGN (see below), is located on the
X chromosome. The two Chrnb22/2mutant strains potentially
express combinations of X alleles from the 129/SvEv, HM1,
DBA/2 and/or C57BL/6J lines [20]. Increased expression of this
gene in mutant LGNs may reflect the differences in X
chromosome alleles relative to C57BL/6J control expression
rather than lack of CHRNB2. As previously mentioned,
expression of the Pisd-ps3 pseudogene family is reduced in mutants
for both tissues and ages examined. However, two probe sets
(1453144_at and 1453145_at) are also detected significantly less in
Picciotto than in Xu Chrnb22/2mutant mice, indicating a
potential background strain effect for at least some of these loci.
Chrnb2 mRNA expression is downregulated in P4 mutant
mouse tissues
The Picciotto and Xu Chrnb22/2mutants are created by two
distinct procedures. In the Picciotto mutant a small portion of the
gene around the start codon and the signal peptide has been
replaced with a lacZ-neomycin resistance construct [17]. Xu
mutants have the first five (of six total) exons replaced with a
neomycin resistance cassette [23] (Figure 2A). Expression of
Chrnb2 mRNA was dramatically lower in microarray analysis of
tissues from both mutants (Table 2). However, the Chrnb2 probe
set 1436428_at consistently showed less expression in Xu animals
than in Picciotto animals (Table 2). To determine whether
Picciotto mice make a small amount of Chrnb2 mRNA, RT-PCR
was performed with primers spanning exons 3–5 (Figure 2A and
B). Several in-frame potential start codons immediately down-
stream of the canonical AUG start codon remain in Picciotto mice
and Chrnb2 mRNA is detectable in Picciotto P4 retina and LGN,
while no Chrnb2 mRNA is detected in Xu mutant amplifications
(Figure 2B). The amount of mRNA made is small, and CHRNB2
protein is not detected in Picciotto retina by Western blot [17] or
by IHC (Figure 2C and D). Furthermore, the phenotypes of the
Picciotto and Xu animals with respect to retinal wave activity and
LGN segregation are similar [15], suggesting that the small
amount of mRNA made in Picciotto animals does not affect their
mutant status. However, detection of this mRNA on the
microarray scan and its subsequent verification by RT-PCR
analysis indicates the sensitivity of the microarray assay.
Expression of calcium signaling and cell adhesion genes
is reduced in P4 mutant LGNs
Exclusive of the Chrnb2 index gene, 32 transcripts are
downregulated in mutant P4 LGNs using the selected stringency
criteria (Figure 3A;Table S2). Of the annotated genes, 22 are
membrane proteins or are found in the extracellular matrix. Of
special interest among these is Lypd2 (Lynx2), a known
endogenous bungarotoxin-like inhibitor of nAChRs. Five tran-
scripts are associated with calcium binding and/or signaling
(Anxa1, Cdh1, Mgp, S100a10 and Thbd) and six have known cell
adhesion functions (Cdh1, Cldn11, Col12a1, Ctgf, Mpzl2, and Spp1).
Cdh1 (E-cadherin, cadherin 1) expression is remarkably sup-
pressed: (12 to 18 fold less in both mutant strains vs WT,
Figure 3A; Table S2) and this difference in expression was
confirmed by RT-PCR and IHC (Figure 3B and C).
Only four transcripts are upregulated in P4 Chrnb22/2mutant
LGN by the criteria chosen (Figure 3A). These genes show
considerable variability between the two types of mutant and may
be differentially expressed due to the different genetic background
of the three types of mice compared (see above).
SPP1 is a known axon guidance regulator [24]. Spp1 mRNA
was confirmed to be reduced in P4 Chrnb22/2mutant LGN and
absent from Spp12/2 P4 mutant LGN by RT-PCR (Figure 4A).
At P4, LGN eye specific segregation is not evident in WT,
Table 1. RT-PCR primers.
Gene symbol
Tissue
ampli-fied Forward primer Reverse primer
Expected
cDNA size
(bp) Comment
Actb Retina, LGN gaaatcgtgcgtgacatca aacgcagctcagtaacagt 535
Chrnb2 Retina, LGN gtatcattggcacagctca gcaatgaagcgtacaccgt 1120
Pisd-ps3
(Rik4933439C20)
Retina, LGN ctcttggtggtctttcaag agaaactctacagacgcca 270 Multiple
chromosomal loci
Plac9 Retina aggcgactacggacaaact ttgcacaggtcacccaggt 590
Ccl21 (6CKine) Retina gatgactctgagcctcctt gtctgttcagttctcttgca 370
Rik4933409K07 Retina caagtctgtgttgacatgga ttaataatgtacagcagagaca 715
Crb1 retina cttgtgtctgccctcaaga gtgcagcccaggagaattt 710 4 known isoforms
Xlr3a LGN caattactggttagcacacat tatccatacaagtgagggat 420
Spp1 LGN agaagcatccttgcttgggt cttcatgtgagaggtgaggt 615
Cdh1 LGN cccaagttgcccagttct atcttagagaacggtttcaat 545
Lypd2 LGN ttggcactgatattgggca ccatggctttacagcagga 370
doi:10.1371/journal.pone.0018626.t001
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has developed in the WT and Spp12/2 mutant but not in the
Chrnb22/2mutants (Figure 4B).
Expression of genes associated with neuronal
degradation is increased in P4 but not in adult
Chrnb22/2 mutant mouse retinas
In contrast to the P4 LGN in which nearly all differentially
expressed genes showed decreased expression in mutants, 11 of 12
genes (Chrnb2 excluded) with significantly altered expression in P4
retina show an increased expression in the Chrnb22/2mutants
(Figure 5A; Table S2). Seven of these gene products are found in
the membrane and extracellular space (EPB4.1, EPB4.1L2,
D14ERTD449E, SEC61A1, CRB1, CCL21 and CP), as is the
index protein CHRNB2. Three products of upregulated genes
(CRB1, CP and CCL21) are associated with retinal injury or
degenerative processes. Although expression of these genes is
upregulated in P4 Chrnb22/2mutant mice, retinas from these
mice are phenotypically normal (Figure 2C, 5C and D).
Immunohistochemistry confirmed the presence of CCL21 protein
in Chrnb22/2mutant retina outer segment (OS) and outer and
inner plexiform layers at P4 compared to WT (Figure 5C).
Microarray comparisons of adult retinas showed little consistency
with expression changes found in P4 retina. Of particular
interest, elevated CCL21 protein levels were detected by IHC in
Chrnb22/2mutant retinas at P4, as predicted by the microarray
result, but not in adult mutant or WT retina, also consistent with
the microarray result (Figure 5D).
Effects of the Chrnb22/2 mutation are tissue- and
temporally specific
Only one set of microarray probes, for Pisd-ps3 (Riken
4933439C20) shows reduced expression in both mutants in P4
LGN and in P4 and adult retinas by the selection criteria chosen
(Figures 3A, 5A, and 6). The microarray probes detect
transcripts of this phosphatidylserine decarboxylase pseudogene
that arise from loci on five different chromosomes (5, 11, 14, 17
and Y). While expression is significantly reduced in both types
of mutant P4 LGNs vs WT, Xu mutants show considerably less
expression than Picciotto mutants for at least three probe
sets (Table S2), raising the possibility that expression is
affected by genetic background in addition to the Chrnb22/2
mutation.
Expression of cdh1 mRNA is low and indistinguishable in both
P4 and adult mutant and WT retinas, but expression of CDH1 is
considerably reduced in P4 Chrnb22/2mutant LGN (Figure 3C).
Lack of CDH1 is an embryonic-lethal defect in mice [25], and
both Chrnb22/2mutants develop normally to adulthood. Either
enough CDH1 is made in Chrnb22/2mutants to assure viability
(though below the detection threshold of IHC), or the reduced
expression in P4 LGN is localized. Expression of the immune
response indicator CCL21 (chemokine (C-C motif) ligand 21;
6CKINE) is increased in P4 Chrnb22/2mutant retina, but not in
adult mutant retina (Figure 5C and D). Microarray analysis reveals
no difference in Ccl21 mRNA expression between mutant and
WT P4 LGN.
Discussion
Chrnb22/2mutant mice display altered retinal waves
and abnormal neuronal connections in the visual
circuitry of the LGN
Mice lacking the Chrnb2 subunit exhibit abnormalities in their
visual circuitry. Retinal ganglion cells of WT mice display retinal
waves before eye opening, but Chrnb22/2mutants have been
reported to lack retinal waves between P1–P8 and lack refinement
of projecting RGCs within the LGN [2]. It has been proposed that
spontaneous retinal wave activity is a prerequisite for correct eye-
specific axonal segregation in the LGN [7,26], and the findings
that Chrnb22/2mutant mice lacked both cholinergic retinal waves
and refined axonal targeting to the LGN supported this
hypothesis.
Recently, this laboratory has reported that two strains of
Chrnb22/2 mutant mice [17,23] do display spontaneous retinal
Figure 1. Differential gene expression between P4 Pic and Xu
Chrnb22/2 mutant retinas and LGNs. A. Heat map of genes
differentially expressed between the two mutant P4 LGNs. B. Heat map
of genes differentially expressed between the two mutant P4 retinas.
Gene names are in Table S4.
doi:10.1371/journal.pone.0018626.g001
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temporal patterning. We also confirmed that RGC targeting
abnormalities are present in the LGN for both Chrnb22/2
mutants despite the presence of spontaneous retinal waves [15].
These results indicate that the presence of these abnormal retinal
waves is not sufficient to drive development of a normal pattern of
eye specific segregation in the LGN [15,16]. It is not clear what
aspects of retinal activity patterns may be involved in the normal
development of retinogeniculate projections (for review see [27]).
However, it seems clear that altered patterns of gene expression
must be involved in the altered RGC projection pattern seen in the
mutant animals. To determine what molecular factors might be
associated with Chrnb2 mutation at the age when cholinergic waves
are normally present (P1–P8), we assayed RNA populations in
both mutant and WT (C57BL/6J) mouse LGN and retinal tissue
at P4 by microarray hybridizations. Adult retinas were also
assayed and gene expression compared to age matched WT
animals.
Comparison of two different mutants relative to wild
type controls reveals the effect of background strains
upon the RNA population
While the use of single-gene mutants to elucidate gene function
is a powerful tool, many authors have cautioned that the methods
by which these knockout animals are prepared may not reveal the
true contribution of the knocked out gene to the transcriptional
profile compared with ‘‘control’’ animals [19,20,21]. The
genetically ‘‘pure’’ C57BL/6J strain, the strain used as the control
in our study and a genetic contributor to both Chrnb22/2
Figure 2. Genotypes and validation of Chrnb22/2 mutants. A. The structures of the Chrnb2 gene in WT and Pic (Piccotto) and Xu mutants.
Exons are numbered solid boxes. The positions of the primers used in (B) are solid black lines and arrows shown below the WT diagram. B. RT-PCR
amplifications of Chrnb2 from P4 retinal and LGN mRNA. The forward primer spans the exon 2–3 junction. The reverse primer is located at the 39 end
of exon 5. (see A) Primer sequences are given in Table 1. The expected cDNA product is 1120 bp. Note that Pic mice express some Chrnb2 mRNA
while Xu mice do not. This image was made of a 35-cycle amplification to visualize expression in the Pic mice clearly. At 25 cycles the band in the Pic
lanes is barely visible (not shown). * indicates an unloaded lane. ‘‘Control’’ is without template. Actin amplification controls are shown in Figure S1.
C. Confocal images of retinal tissue using an antibody to CHRNB2 (sc-1449). INL; inner nuclear layer; IPL, inner plexiform layer; GCL; ganglion cell layer.
Scale 50 mm. D. Confocal images of P4 LGN tissue using an antibody to CHRNB2 (sc-1449). The region occupied by the LGN expresses CHRNB2. Scale
200 mm. In C and D, DAPI counterstain is pseudocolored green and anti-CHRNB2 is red.
doi:10.1371/journal.pone.0018626.g002
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Kedmi and Orr-Urtreger [19] compared brain RNA from
Chrnb42/2 mutants with C57BL/6J in a microarray analysis.
The Chrnb42/2 mutants used were generated by a process similar
to the Xu Chrnb22/2 mutants presented in this work [23]. Kedmi
and Orr-Urtreger report that ten of the 77 genes with altered
expression in the Chrnb4 mutants were co-localized with the
Chrnb4 gene on chromosome 9 [19]. Thus, 13% of the differences
they found could result from the recombination that created the
mutant, leading to altered expression of adjacent genes on the
same chromosone.
Chrnb2 is located on Chr3 and examination of our data reveals
that four genes we score as having significantly different expression
are also located on chromosome 3: S100a10 and Cldn11 in P4
LGN, Cp in P4 retina, and Gstm1 in adult retina. Of these, S100a10
and Gstm1 lie very close to Chrnb2 at Chr3F and differences in their
expression may be a result of the mutation process rather than the
lack of CHRNB2.
We find no genes differentially expressed in common with mice
lacking the Chrnb4 gene, but our tissue, ages, and selection criteria
all vary from that report [19]. However, mutation of Chrnb4 does
lead to changes in expression of calcium ion binding proteins
similar to our results for Chrnb2, indicating that this may be a
pathway generally sensitive to alterations in nAChR subunit
composition. While comparing both independently produced
Chrnb22/2 animals to the selected WT strain does not completely
correct for allelic effects, our analysis of two independently
generated mutants allows a more certain determination of
transcripts affected by the lack of CHRNB2. At least two genes
with consistently different expression between both mutants and
WT (Xlr3a and Pisd-ps3, see Results) appear to show an additional
background strain effect on their expression.
Genes overexpressed in P4 mutant retinas are associated
with membranes and neuronal injury
In P4 retinas, mutation of Chrnb2 is generally associated with an
increase in expression of eleven transcripts and decreased
expression of only one, the Pisd-ps3 family. Three genes
overexpressed in P4 Chrnb22/2 mutant retina relative to WT
are associated with retinal injury (Crb1, Ccl21a/b/c, and Cp).
CCL21 is a ligand expressed by injured neurons that activates
microglia as part of the inflammatory response. Retinas from mice
lacking CHRNB2 show 8-fold overexpression of Ccl21 by
microarray analysis. CCL21 is overexpressed in the OS, OPL
and IPL of P4 Chrnb22/2 retinas compared with WT. Photic
injury to the adult retina has been reported to increase expression
of one member of the CCL21a/b/c chemokine family, Ccl21a (aka
Scya21a) by more than four-fold in the ONL [29].
Why the P4 Chrnb22/2 mice, which have not been exposed to
abnormally high light levels, synthesize large amounts of CCL21
in their retinas is not known. Unlike the pyknotic nuclei and other
cellular abnormalities reported in photic injured retinas [29], gross
retinal anatomy appears normal in the Chrnb22/2 mutant mice.
Adult brains of Picciotto Chrnb22/2 mutants have been reported
to show increased neuronal atrophy and microgliosis [30], but
whether these changes are accompanied by increased CCL21
expression in aged mutant brain is not known.
Expression of ceruloplasmin (Cp) mRNA has also been reported
to be upregulated in response to photic damage [31] and we find
overexpression of Cp mRNA in P4 Chrnb22/2 mutant retina
relative to WT (see Results). CP facilitates iron transport and
serves as an antioxidant by oxidizing the free radical catalyst Fe
2+
to Fe
3+ [32]. CP has been previously reported in healthy mouse
[33] and human retina [34]. Mouse and human glaucomatous
retinas show an upregulation of CP during the period when RGC
death is occurring due to increased intraocular pressure [35]. It is
of interest to note that CP in the glaucomatous retina is localized
to Mu ¨ller cells in the inner nuclear layer and astrocytes in the
RGC layer. We did not conduct immunohistochemistry for CP,
but if increased CP is localized in the RGC layer of mutant
animals, it would provide evidence that P4 Chrnb22/2 mice have
higher rates of RGC death compared to WT animals. Although
RGC death cannot directly explain the altered segregation pattern
in the mutant mice, it may alter the molecular gradients or retinal
activity levels in the Chrnb22/2 mutant retina that lead to this
developmental aberration.
Mutation of CRB1 (crumbs1) is associated with Leber’s
congenital retinopathy and retinitis pigmentosa in humans
[36,37,38] We see high Crb1 expression in P4 Chrnb22/2 retinas
compared to WT animals. CRB1 is localized in the subapical
region of Mu ˝ller glial cells in the mouse retina [38], a structure
adjacent to the adherens junction. In P4 retina expression of the
adherens junction component CDH1 is low and similar in WT
and mutant mice, but expression of CDH1 is reduced in LGNs of
Chrnb22/2 mice at this age. Xu et al [39] examined WT retinas
at E12, E14, E16, P7, P14 and P30. Cdh1 mRNA was transiently
detected only at P14, in a subset of RGCs. It is possible that
transient Cdh1 expression at an age they did not assay (e.g., E17 –
P4) may be eliminated by lack of CHRNB2 in the retina, and that
Table 2. Chrnb2 mRNA expression in P4 Xu and Picciotto Chrnb22/2 LGN and retina vs WT.
LGN expression probe set WT A WT D * KO A KO B KO C fold change
Xu vs WT 1436428_at 313 296 8 5 4 60.4
Xu vs WT 1441837_at 86 85 8 12 16 7.5
Pic vs WT 1436428_at 313 296 39 57 54 6.0
Pic vs WT 1441837_at 86 85 12 12 8 8.0
Retina expression WT A WT B WT C KO A KO B KO C fold change
Xu vs WT 1436428_at 103 127 124 19 9 14 8.9
Xu vs WT 1441837_at 12 8 18 30 9 8 0.81
Pic vs WT 1436428_at 103 127 124 26 30 25 4.4
Pic vs WT 1441837_at 12 8 18 11 11 13 1.1
*Only two WT LGN microarrays were used (see Methods).
doi:10.1371/journal.pone.0018626.t002
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PLoS ONE | www.plosone.org 6 April 2011 | Volume 6 | Issue 4 | e18626Figure 3. Differential CDH1 expression in P4 LGN. A. Heat map of genes differentially expressed between both mutants and WT selected from
the microarray assay. Note that only four genes are overexpressed in mutant LGN and expression of these differs greatly between the Pic and Xu
mutants. Redundant probesets have been stripped from the map. When a gene symbol is available it appears next to the probeset. Gene names are
in Table S4. B. Validation qualitative RT-PCRs for some of the genes in (A). ‘‘Control’’ is without template. Primers used are given in Table 1. Actin
amplification controls are shown in Figure S1. C. Confocal images of tissue sections demonstrating the absence of CDH1 protein in mutant LGN.
Nuclei are counterstained with DAPI and pseudocolored green. CDH1 (arrows) is expressed discretely within the cell membrane. Scale bar 25 mm.
doi:10.1371/journal.pone.0018626.g003
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PLoS ONE | www.plosone.org 7 April 2011 | Volume 6 | Issue 4 | e18626this transient defect in the adherens junction leads to subsequent
compensatory overexpression of CRB1.
CRB1 shares calcium binding properties with CHRNB2 and
activation of nicotinic AChRs increases calcium trafficking at the
synapse [40,41]. Calcium is a known neuronal transcriptional
regulator [42] and a lack of the CHRNB2 subunit in retina may
affect transcription by altering Ca
2+ ion flow at the synapse. CRB1
is required to prevent light-induced retinal degradation in
Drosophila [43] and mice [37]. We speculate that increases of
CCL21, CP, and CRB1 may indicate the death of a subset of
RGCs that contain molecular markers which determine the
localization of the RGC axons in the LGN. A similar process
occurs in the formation of superior colliculus topography [44].
Death of a significant number of RGCs that project to a specific
region could cause the altered segregation pattern evident in
Chrnb22/2 LGN.
Chrnb22/2 mutation in P4 LGNs is associated with
reduced expression of the axon growth regulators
cadherin 1, Lypd2 and secreted phosphoprotein 1
Knockout mutation of Chrnb2 is associated with a decrease in
transcript expression in the P4 LGN as 32 of 36 transcripts with
altered expression show a reduction of expression in the mutants
(see Results). Mutant LGNs at P4 show a diffuse segregation
pattern of ipsilateral and contralateral RGC axons compared with
WT [6,15]. The segregation begins to resolve with age, but never
becomes as focused as in the wild type animals [6]. These findings
indicate that the formation of a normal eye-specific segregated
pattern may require an expression pattern of specific genes during
the first postnatal week that is altered in the Chrnb22/2 mutant
LGNs.
Given the displacement of RGC axonal projections in the
Chrnb22/2 mutant LGNs, it is of interest that expression of
mRNAs encoding SPP1 (secreted phosphoprotein 1, osteopontin),
LYPD2 (LY6/PLAUR domain containing 2, Lynx2) and CDH1,
proteins with known axon guidance properties, are significantly
lower in P4 mutant LGN compared to the age matched WT.
Various effects of SPP1 on axon growth have been reported. Ries
et al [45] find a mild enhancement of axon growth by SPP1 in an
in vitro assay using purified rat E20 RGCs while in an in vitro
growth assay of effects on dorsal root ganglia showed SPP1 in the
substrate inhibited outgrowth and caused fasciculation [24].
Spp12/2 mutant mice are grossly normal [46] and the RGC
projection pattern in the LGNs of P4 Spp12/2 mutant mice
appears equivalent to WT. Reduced SPP1 does not cause the
segregation defect.
The association of SPP1expression with neuronal degeneration in
the rodent brain [47] and retina [48] is of interest. We find increased
expression of mRNAs for two genes associated with retinal injury,
Ccl21 and Crb1,i nChrnb22/2 mutant retinas at P4 and decreased
expression of Spp1 mRNA in mutant LGNs at P4. Zoli et al [30]
describe neurodegenerative changes in the brains of aged Picciotto
Chrnb22/2 mutant mice. Spp1 expression appears to be tissue-
dependent inChrnb22/2 mutantmice, butwhether itplaysa rolein
neuronal injury response in these animals is not known.
Figure 4. Spp1 expression and RGC segregation in WT Spp12/2 and Chrnb22/2 LGN. A. Validation qualitative RT-PCRs for the Spp1 gene
in P4 WT, Chrnb22/2 and Spp12/2 LGNs. Spp1 RNA amplification is low in Chrnb22/2 LGN and is not evident in Spp12/2 LGN compared to WT.
Actin amplification controls are shown in Figure S1. B. RGC segregation in WT and mutant LGN. At P4 eye specific segregation has not developed in
any animals tested. At P8 eye specific segregation in the LGN has developed in WT and Spp12/2 mutants but not in Chrnb22/2 mutants.
Choleratoxin-ß conjugated to Alexa 594 (red) and Alexa 488 (green); Scale 100 mm.
doi:10.1371/journal.pone.0018626.g004
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LGNs. LYPD2 is an Ly6 superfamily member closely related to
LYNX1, a known modulator of a4ß2 nAChRs [49,50,51,52,53].
Members of the Ly6 superfamily are present at the tips of growing
axons and participate in cell adhesion [52]. LYPD2 is transiently
expressed in sensory neurons in the CNS during mouse embryonic
development [52]. Morishita et al [53] show that expression of
LYNX1 acts as a ‘‘molecular brake’’ by binding to nAChRs in the
visual cortex and inhibiting neuronal response at the conclusion of
the binocular visual critical period. It is possible that LYPD2 may
act in a similar inhibitory manner to focus the segregation of
ipsilateral and contralateral axons in the LGN during the retinal
wave critical period ending at P8.
CDH1 expression is strongly downregulated and is not
detectable in P4 Chrnb22/2 mutant LGN. While more detailed
analysis is required to address whether genes isolated in the
microarray experiments are associated with the reported visual
system defects, the finding that CDH1 is specifically down-
regulated in the Chrnb22/2 mutant LGN is novel and intriguing.
CDH1 and CDH2 (N-cadherin) are prototypes of a large family of
adhesion molecules that play important roles in the development
of the nervous system [54,55,56]. Numerous cadherins, including
CDH2, are broadly and dynamically expressed in the developing
brain and serve diverse functions ranging from control of neuronal
morphogenesis to regulation of axonal connections and synapse
formation [57]. In contrast, CDH1 is associated with non-
neuronal epithelial cells, but expression in the nervous system
has been documented [58,59,60]. Furthermore, it has been
reported that CDH1 is present in chick RGCs and tectum and
is required for growth of RGC axons to the tectum [61]. In mice,
however, Cdh1 transcript was not found in embryonic or postnatal
retinas tested until P14 [39], consistent with our microarray data
for P4.
Our microarray data show expression of Cdh2 mRNA in retina
and LGN is high and unaltered in P4 Chrnb22/2 mutant mice. It
has been established that cadherins, including CDH1 and CDH2,
regulate cell-cell interactions through homophilic binding [55].
Neurons and neurites expressing CDH1 or CDH2 are differen-
Figure 5. Differential gene expression in P4 retina. A. Heat map of genes differentially expressed between both mutants and WT selected from
the microarray assay. Note that only one gene other than Chrnb2 is downregulated in the mutants (Pisd-ps3). Redundant probesets have been
stripped from the map. When a gene symbol is available it appears next to the probeset. Gene names are in Table S4. B. Validation qualitative RT-
PCRs for some of the genes in (A). ‘‘Control’’ is without template. Primers used are given in Table 1. Amplification with Crb1 primers yields three
bands. The Expasy (www.expasy.org) annotation for mouse Crb1 gives four known splice variants. C. Confocal images of P4 retina using an antibody
to CCL21 (aka 6CKine). CCL21 protein is strongly expressed in the outer segment (OS), and outer plexiform layers (OPL) and weakly in the inner
plexiform layer (IPL) of Chrnb22/2 but not WT retinas. D. Confocal images of adult retina using an antibody to CCL21 (aka 6CKine). CCL21 protein
appears in the outer segment (OS) and outer plexiform layer (OPL) of all animals. Anti-CCL21 (red), DAPI nuclear counterstain (pseudo colored green).
Scale 25 mm.
doi:10.1371/journal.pone.0018626.g005
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reported that CDH1 and CDH2 are present in interneuronal
synapses and mediate synaptic adhesion [62]. Because CDH2 is
associated with excitatory synapses in cultured hippocampal
neurons [63], it has been suggested that CDH1 may be associated
with inhibitory synapses [64]. Ablation of CDH1 expression in
mutant LGN may interfere with the sorting of axonal projections
leading to the defects seen in the Chrnb22/2 mutant visual
system.
We recognize the limitations of extrapolating from microarray
and RT-PCR analysis to protein expression. Nontheless, based on
these RNA analyses, it is tempting to hypothesize that deficits of
the axon growth regulators CDH1 and LYPD2 are responsible for
the diffuse localization of ipsilateral RGC projections in the LGNs
of Chrnb22/2 mutants. Matter et al [65] proposed that invasion
of the chick tectum by RGCs activates expression of CHRNB2. If
the same process occurs in the rodent, a mechanism suggests itself:
RGCs enter the LGN but without nAChR ß2 subunits,
postsynaptic Ca
2+ activation of transcription is abnormal and
expression of CDH1 or LYPD2 in LGN neurons is weakened. The
accuracy of neuronal connections in the LGN therefore may be
compromised by the altered expression of axon guidance and
adhesion molecules at the thalamic level.
Supporting Information
Figure S1 Actin controls for RT-PCRs. Actin amplification
controls for RT-PCRs shown in Figures 1–4. Primers are given in
Table 1. Ten ng of each prepared RNA template in a 25 ml
reaction volume was amplified for 20 cycles. ‘‘Control’’ lanes were
amplified without template.
(TIF)
Table S1 Excel spreadsheets of present calls for all the
microarrays.
(XLS)
Table S2 Excel spreadsheets of all mutant vs WT
comparisons.
(XLS)
Table S3 Excel spreadsheets of all Pic vs Xu compar-
isons.
(XLS)
Table S4 Gene Abbreviations and Names from
Figures 1, 3 and 5.
(XLS)
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